Human pathogenic arenaviruses.
Solbrig
Marylou V
MV
D000998:Antiviral Agents / Q000627:therapeutic use; D018050:Arenavirus / Q000502:physiology*; D001921:Brain / Q000503:physiopathology / Q000821:virology; D021821:Communicable Diseases, Emerging / Q000150:complications / Q000503:physiopathology; D003638:Deafness / Q000503:physiopathology / Q000821:virology; D003937:Diagnosis, Differential; D018450:Disease Progression; D042241:Early Diagnosis; D018792:Encephalitis, Viral / Q000175:diagnosis* / Q000503:physiopathology* / Q000821:virology; D006801:Humans; D007113:Immunity, Innate / Q000276:immunology; D007835:Lassa Fever / Q000150:complications* / Q000503:physiopathology*; D007836:Lassa virus / Q000502:physiology*; D015996:Survival Rate; D016896:Treatment Outcome
D000998:Antiviral Agents